London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here

Come to London


WATCH to find out why

Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


Search Abstracts by author or title
(results will display both Free Papers & Poster)

Clinical performance of a multifocal intraocular lens (+2.00D addition) with a rotationally asymmetric design

Poster Details

First Author: R.Morris UK

Co Author(s):    O. Bowen-Thomas   A. Hartwig   R. Walsh   J. Dermott   C. O'Donnell  

Abstract Details


To evaluate the clinical outcomes with a rotationally asymmetric, +2.00D add power multifocal intraocular lens (IOL) design.


Optegra Solent Eye Hospital and Optegra Surrey Eye Hospital


Observational case series. Twenty-eight patients (49 eyes) underwent Lentis® LS-313 MF20 implantation by a single surgeon at two sites. Pre- and post-operative monocular uncorrected distance (UDVA) and near (UNVA) vision was recorded along with corrected distance and near visual acuity (CDVA and CNVA respectively) and operative and post-operative complication rates.


Patients ranged in age from 46 to 76 years (mean±SD 63±8 years). Mean monocular pre-operative and post-operative UDVA was LogMAR 0.68±0.69 and 0.00±0.09 respectively (p<0.05). Pre-operative and post-operative CDVA was LogMAR 0.05±0.1 and -0.07±0.06 respectively (p<0.05). 100% of eyes achieved UDVA 6/9 or better and 71% of eyes achieved 6/6 or better postoperatively. 96% of eyes achieved UNVA N8 or better unaided. Binocularly all patients achieved combined 6/7.5 and N6 unaided and 81% of patients achieved combined 6/6 and N5 unaided. There were no operative complications and few post-operative complications (PCO, mild iritis) recorded. There was a low incidence of dysphotopsia symptoms reported.


The Lentis® LS-313 MF20 IOL is an effective way to enhance both distance and near vision following phacoemulsification surgery. FINANCIAL INTEREST: NONE

Back to Poster listing